Nilotinib, for Patients With CML-CP or CML-AP

NCT04518644 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Chronic Myelogenous Leukemia (CML)

Interventions

DRUG: Nilotinib

Sponsor

Novartis Pharmaceuticals